Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.580
+0.070 (1.55%)
At close: Jun 16, 2025, 4:00 PM
4.670
+0.090 (1.97%)
After-hours: Jun 16, 2025, 5:08 PM EDT

Vanda Pharmaceuticals Market Cap

Vanda Pharmaceuticals has a market cap or net worth of $269.92 million as of June 16, 2025. Its market cap has decreased by -7.43% in one year.

Market Cap
269.92M
Enterprise Value
-59.24M
1-Year Change
-7.43%
Ranking
Category
Stock Price
$4.58

Market Cap Chart

Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $269.92M, an increase of 28.84%. That is a compound annual growth rate of 1.33%.

History

DateMarket Cap% Change
Jun 16, 2025269.90M-3.37%
Dec 31, 2024279.30M15.03%
Dec 29, 2023242.80M-41.94%
Dec 30, 2022418.20M-52.16%
Dec 31, 2021874.10M21.64%
Dec 31, 2020718.60M-17.90%
Dec 31, 2019875.30M-36.13%
Dec 31, 20181.37B100.69%
Dec 29, 2017682.90M-2.57%
Dec 30, 2016700.90M75.84%
Dec 31, 2015398.60M-17.90%
Dec 31, 2014485.50M17.87%
Dec 31, 2013411.90M294.54%
Dec 31, 2012104.40M-21.97%
Dec 30, 2011133.80M-49.57%
Dec 31, 2010265.30M-13.30%
Dec 31, 2009306.00M2,200.75%
Dec 31, 200813.30M-92.75%
Dec 31, 2007183.40M-66.04%
Dec 29, 2006540.00M157.76%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 724.99B
Johnson & Johnson 373.47B
Novo Nordisk 343.59B
AbbVie 337.14B
UnitedHealth Group 279.09B
Abbott Laboratories 233.16B
Novartis AG 232.80B
AstraZeneca 228.09B
Market Cap Rankings